Ray Kall

Ray Kall has extensive work experience in the pharmaceutical industry. Since June 2020, they have been working as the Executive Director of National, Federal, and Regional Accounts at AVEO Oncology. In this role, they have built and led the Market Access team, launched the company's first oncology product, and developed strategic payer account strategies. Ray has also collaborated with various departments and organized the training and development of the National Account Director team.

Prior to joining AVEO Oncology, Ray worked at Sanofi Genzyme as the National Account Director for Oncology/Transplant and as a Regional Account Director. Ray was responsible for market access in the areas of Multiple Sclerosis/Immunology and worked closely with health plans to create medical policies and develop plans for healthcare organizations.

Before that, Ray was a National Account Director at Egalet Corporation and held multiple roles at Novo Nordisk, including Director of Market Access, Executive Account Manager, Global Marketing Director, Project Director for Global Selling and Training, Regional Sales Director, and District Manager. In these roles, they demonstrated strong leadership skills, achieved significant sales growth, and successfully launched new products.

Overall, Ray Kall has a proven track record of driving market access, developing strategic partnerships with healthcare organizations, and achieving sales targets in the pharmaceutical industry.

Ray Kall attended Bethpage High School from 1978 to 1982, where they pursued a general education. Following their high school education, from 1984 to 1988, they enrolled in The University of Georgia, earning a Bachelor of Science (BS) degree in Animal Science.